American College of Cardiology Names Ravee Kurian COO/CFO

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

American College of Cardiology reports Ravee Kurian has been named Executive Vice President and Chief Operating Officer/Chief Financial effective July 1. Kurian will lead the global organization’s strategic planning, finance and technology divisions, while working closely with the ACC’s leadership team to advance the College’s digital transformation initiatives.

When the world was hit by the biggest public health crisis of our lifetimes, the ACC’s Board and Staff pivoted quickly to accommodate the rapidly shifting needs of the organization and its members,” Kurian said. “The ACC’s ability to do this without skipping a beat demonstrated exceptional levels of professionalism and commitment by every single person involved. I am honored and humbled to join this dedicated group as a member of the leadership team and I look forward to helping the College move confidently into the future.”

Kurian comes to ACC following a 20-year stint at Publicis Sapient, a leading technology and communications consultancy, where he led critical and sensitive digital transformation initiatives for Fortune 500 and U.S. federal clients.

Over the course of his career, Kurian has worked in a broad range of industries, including aerospace, trucking, insurance, defense and medical research. His most recent experience has been at the National Institutes of Health (NIH) where he worked with researchers, physicians and content strategists to develop a digital-first mindset that helped align their technology investments with how their audiences were interacting with their content. Previously, he also worked at Ernst & Young and at Landauer Associates, a real estate valuation and research firm.

Kurian holds a Master of Business Administration from the Kellogg School of Management at Northwestern University and a Bachelor of Science from the University of Massachusetts at Amherst.



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles